Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography Era

MRI-Guided High–Dose-Rate Intracavitary Brachytherapy for Treatment of Cervical Cancer: The University of Pittsburgh Experience

“…Briefly, the uterus, cervix, parametria, upper vagina, and prophylactic nodal regions were treated to a median dose of 45 Gy (range, 43.2-48.6 Gy) in 1.8-Gy fractions. Involved nodal regions predominantly were treated with a concomitant boost of 55 Gy in 25 fractions (20). Parametrial boosts were completed using a 3D conformal AP-PA technique with a 6-cm midline block for a median dose of 5.4 Gy (range, 3.6-9.0 Gy) in 1.8-Gy fractions.…”

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk

“…[1][2][3][4][5][6][7][8] Despite this proof-of-principle among several disease sites, it remains unclear whether pelvic LN irradiation stands to improve outcomes for patients with prostate cancer (PC).…”

Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer

“…Two centres would advise neoadjuvant platinum-based systemic treatment when there are bulky para- aortic lymph nodes, and one centre would advise neoadjuvant cisplatin in case of a bulky primary tumour. However, more evidence for neoadjuvant and adjuvant chemotherapy is expected, since the INTERLACE and the OUTBACK studies are still in progress [36,37].…”